UnitedHealth Group Stock Stabilizes After Strong Q2 Earnings Beat

UnitedHealth Group Inc.'s stock has steadied after delivering a strong second quarter earnings beat and confirming full-year 2026 EPS guidance.

The company's second-quarter earnings per share (EPS) of $6.38 was well ahead of analyst consensus at $4.94 for the period ended June 30, 2026, representing an EPS beat of $1.44 per share.

UnitedHealth Group generated revenue of $112.03 billion in the same quarter, compared with consensus estimates of $110.81 billion, producing a revenue surprise of $1.22 billion on a relatively low topline growth rate.

The company's second-quarter 2026 revenue was reported to be 0.4% higher than in the comparable quarter a year earlier, illustrating that the scale of the business is already high and that incremental growth is modest in percentage terms.